Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 10, 2015

View Archived Issues

Preclinical and phase I efficacy of a first-in-class ADC against tumor-initiating cells

RedHill Biopharma reports additional data from phase III RHB-105 study

Domain Therapeutics identifies mGlu2/3 receptor modulators for PD non-motor symptoms

GeoVax's Ebola vaccine shows efficacy in rodent models

Pierre Fabre and Addex Therapeutics form CNS program agreement

Recent agreements to develop cancer drugs and diagnostics

Faron Pharmaceuticals announces share offer to fund phase III trial of Traumakine

Purdue Pharma acquires rights to TrkA program from VM Pharma

Canadian funding for VBI Vaccines' development of RSV vaccine

New antimalarial classes discovered at the Walter Reed Army Institute

FDA grants priority review to ixazomib for relapsed/refractory multiple myeloma

Santhera receives European approval for Raxone in Leber's hereditary optic neuropathy

University of New Mexico and HHS discover new PCSK9 vaccine

Team in France introduces AAC-11-LZ-derived polypeptides

Achillion presents complement factor D inhibitors

Shanghai Haiyan Pharmaceutical Technology introduces selective inhibitors of mutant EFGR

EPIRUS patents Nav1.7 channel blockers

Responses seen with TargomiRs in mir-16-deficient mesothelioma

Bioequivalence shown for potential biosimilar PF-06439535 and bevacizumab in healthy volunteers

Novo Nordisk and MIT to explore next generation of drug delivery devices

Rockwell Medical launches Triferic for iron deficiency in the U.S.

Recent acquisition news

Progression-free survival improved with anlotinib in refractory NSCLC

Grant supports Treeway's investigation into ALS diagnostic tool

Janssen-Cilag seeks European approval for daratumumab in multiple myeloma

Cara Therapeutics starts pivotal phase II/III trial for CR-845 in acute postoperative pain

GenSpera reports interim results from phase II trial of mipsagargin in glioblastoma

Trimel Pharmaceuticals changes name to Acerus Pharmaceuticals

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...